Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Conditions
Interventions
Placebo
Neridronic acid 62.5 mg
Locations
59
United States
Site US119 - G & L Research
Foley, Alabama, United States
Site US117 - Valley Pain Consultants
Scottsdale, Arizona, United States
Site US116 - Arizona Pain Specialists
Scottsdale, Arizona, United States
Site US124 - Quality of Life Medical and Research Centers LLC
Tucson, Arizona, United States
Site US154 - Woodland International Research Group
Little Rock, Arkansas, United States
Site US110 - Orange County Research Institute
Anaheim, California, United States
Start Date
April 1, 2015
Primary Completion Date
August 1, 2016
Completion Date
November 1, 2016
Last Updated
May 9, 2018
Lead Sponsor
Grünenthal GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions